SCHEMBL26324897

SCHEMBL26324897

CCCCN(c1ccc(C)cc1)C(C(=O)OC(C)C)C(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.34
POLB P06746 1/20 0.34
MLYCD O95822 1/20 0.33
ABHD10 Q9NUJ1 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
KCNH2 Q12809 1/20 0.32
PPARG P37231 1/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
CNR2 P34972 1/20 0.32
ALDH1A1 P00352 2/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
GPX4 P36969 1/20 0.32
PAX8 Q06710 1/20 0.32
CYP3A4 P08684 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26324895 0.88 CHRNB2 (0.37) MEN1KMT2AKCNH2PPARGPPARD
SCHEMBL26324890 0.88 ALDH1A1 (0.39) RAB9APOLBMEN1KMT2ALMNA
SCHEMBL25439783 0.86 RAB9A (0.35) RAB9APOLBMLYCDABHD10MEN1
SCHEMBL26324900 0.83 SMN1; SMN2 (0.38) RAB9AMLYCDMEN1KMT2ALMNA
SCHEMBL26324912 0.83 HDAC3 (0.32) LMNA
SCHEMBL26324915 0.82 HDAC3 (0.38) RAB9ALMNAPPARGPPARANPC1
SCHEMBL26324909 0.81 PPARG (0.31) LMNAPPARGPPARDPPARA
SCHEMBL26324888 0.80 ALDH1A1 (0.41) POLBMEN1KMT2ALMNAL3MBTL1
SCHEMBL26324906 0.77 PPARG (0.34) PPARGPPARDPPARA
SCHEMBL26324999 0.77 ALOX5 (0.37) RAB9APOLBABHD10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 RAB9A 1447/4885POLB 776/4885MLYCD 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.